Cargando…

Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus

SIMPLE SUMMARY: Mediastinal lymphoma is the most commonly diagnosed tumor in cats with feline leukemia virus infection (FeLV). The cyclophosphamide, vincristine, and prednisolone (COP) chemotherapeutic protocol is widely used and has achieved high complete-response (CR) rates with a long disease-fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaroensong, Tassanee, Piamwaree, Juthaporn, Sattasathuchana, Panpicha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833558/
https://www.ncbi.nlm.nih.gov/pubmed/35158547
http://dx.doi.org/10.3390/ani12030223
_version_ 1784648973351387136
author Jaroensong, Tassanee
Piamwaree, Juthaporn
Sattasathuchana, Panpicha
author_facet Jaroensong, Tassanee
Piamwaree, Juthaporn
Sattasathuchana, Panpicha
author_sort Jaroensong, Tassanee
collection PubMed
description SIMPLE SUMMARY: Mediastinal lymphoma is the most commonly diagnosed tumor in cats with feline leukemia virus infection (FeLV). The cyclophosphamide, vincristine, and prednisolone (COP) chemotherapeutic protocol is widely used and has achieved high complete-response (CR) rates with a long disease-free interval (DFI), and a long median survival time (MST), with low toxicity. The CD4(+)/CD8(+) ratio is used to assess immunity in retroviral infected cats. This study was performed on 18 FeLV-infected cats with mediastinal lymphoma. The complete blood count, creatinine, alanine aminotransferase, and CD4(+)/CD8(+) ratio were measured four times before treating with chemotherapy in the 1st, 2nd, 3rd, and 4th weeks. The white blood cell (WBC) counts, neutrophils, packed cell volume (PCV), and mean corpuscular volume (MCV) changed, while the CD4(+)/CD8(+) ratio was not found to be significantly different. These results suggested that COP chemotherapy is safe as a treatment for FeLV-infected cats with mediastinal lymphoma. ABSTRACT: The objective of this study was to evaluate the effect of the COP chemotherapeutic protocol on hematological parameters, CD4(+)/CD8(+) ratio, and the mortality of 18 client-owned FeLV-infected cats with mediastinal lymphoma. The complete blood count, creatinine, alanine aminotransferase, and CD4(+)/CD8(+) ratio were measured four times before treating with chemotherapy in the 1st, 2nd, 3rd, and 4th weeks. The white blood cell (WBC) counts at the 1st week were significantly different from the 2nd, 3rd, and 4th inductions (p = 0.0075, p = <0.0001, and p = 0.0271, respectively). The neutrophils at the 1st week were significantly different from the 2nd and 3rd inductions (p = 0.0179, and p < 0.0001, respectively). The packed cell volume (PCV) at the 1st week was significantly differed from the 2nd, 3rd, and 4th induction times (p = 0.0029, p = 0.0006, and p = 0.0029, respectively. The mean corpuscular volume (MCV) at the 1st week was significantly different from the 4th week (p = 0.0145). We found that chemotherapy did not cause any significant change in the CD4(+)/CD8(+) ratio (p-value 0.7407). The Kaplan–Meier curves showed the median survival time (MST) for the cats with a CD4(+)/CD8 ratio of less than 1 after the 1st week of chemotherapy was 134 days. This suggested that COP chemotherapy was a safe treatment for FeLV-infected cats with mediastinal lymphoma.
format Online
Article
Text
id pubmed-8833558
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88335582022-02-12 Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus Jaroensong, Tassanee Piamwaree, Juthaporn Sattasathuchana, Panpicha Animals (Basel) Article SIMPLE SUMMARY: Mediastinal lymphoma is the most commonly diagnosed tumor in cats with feline leukemia virus infection (FeLV). The cyclophosphamide, vincristine, and prednisolone (COP) chemotherapeutic protocol is widely used and has achieved high complete-response (CR) rates with a long disease-free interval (DFI), and a long median survival time (MST), with low toxicity. The CD4(+)/CD8(+) ratio is used to assess immunity in retroviral infected cats. This study was performed on 18 FeLV-infected cats with mediastinal lymphoma. The complete blood count, creatinine, alanine aminotransferase, and CD4(+)/CD8(+) ratio were measured four times before treating with chemotherapy in the 1st, 2nd, 3rd, and 4th weeks. The white blood cell (WBC) counts, neutrophils, packed cell volume (PCV), and mean corpuscular volume (MCV) changed, while the CD4(+)/CD8(+) ratio was not found to be significantly different. These results suggested that COP chemotherapy is safe as a treatment for FeLV-infected cats with mediastinal lymphoma. ABSTRACT: The objective of this study was to evaluate the effect of the COP chemotherapeutic protocol on hematological parameters, CD4(+)/CD8(+) ratio, and the mortality of 18 client-owned FeLV-infected cats with mediastinal lymphoma. The complete blood count, creatinine, alanine aminotransferase, and CD4(+)/CD8(+) ratio were measured four times before treating with chemotherapy in the 1st, 2nd, 3rd, and 4th weeks. The white blood cell (WBC) counts at the 1st week were significantly different from the 2nd, 3rd, and 4th inductions (p = 0.0075, p = <0.0001, and p = 0.0271, respectively). The neutrophils at the 1st week were significantly different from the 2nd and 3rd inductions (p = 0.0179, and p < 0.0001, respectively). The packed cell volume (PCV) at the 1st week was significantly differed from the 2nd, 3rd, and 4th induction times (p = 0.0029, p = 0.0006, and p = 0.0029, respectively. The mean corpuscular volume (MCV) at the 1st week was significantly different from the 4th week (p = 0.0145). We found that chemotherapy did not cause any significant change in the CD4(+)/CD8(+) ratio (p-value 0.7407). The Kaplan–Meier curves showed the median survival time (MST) for the cats with a CD4(+)/CD8 ratio of less than 1 after the 1st week of chemotherapy was 134 days. This suggested that COP chemotherapy was a safe treatment for FeLV-infected cats with mediastinal lymphoma. MDPI 2022-01-18 /pmc/articles/PMC8833558/ /pubmed/35158547 http://dx.doi.org/10.3390/ani12030223 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jaroensong, Tassanee
Piamwaree, Juthaporn
Sattasathuchana, Panpicha
Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
title Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
title_full Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
title_fullStr Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
title_full_unstemmed Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
title_short Effects of Chemotherapy on Hematological Parameters and CD4(+)/CD8(+) Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
title_sort effects of chemotherapy on hematological parameters and cd4(+)/cd8(+) ratio in cats with mediastinal lymphoma and seropositive to feline leukemia virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833558/
https://www.ncbi.nlm.nih.gov/pubmed/35158547
http://dx.doi.org/10.3390/ani12030223
work_keys_str_mv AT jaroensongtassanee effectsofchemotherapyonhematologicalparametersandcd4cd8ratioincatswithmediastinallymphomaandseropositivetofelineleukemiavirus
AT piamwareejuthaporn effectsofchemotherapyonhematologicalparametersandcd4cd8ratioincatswithmediastinallymphomaandseropositivetofelineleukemiavirus
AT sattasathuchanapanpicha effectsofchemotherapyonhematologicalparametersandcd4cd8ratioincatswithmediastinallymphomaandseropositivetofelineleukemiavirus